Skip to main
PRLD
PRLD logo

Prelude Therapeutics (PRLD) Market Capitalization Overview

Market Cap: $54.99M as of Jun 16, 2025

$54.99M
Past Month+$2.09M (3.94%)
As of Jun 16, 2025, Prelude Therapeutics (PRLD) has a market capitalization of $54.99M. Over the past 30 days, its market cap has decreased by -1.22%, while in the last 12 months, it has decreased by -21.64%.

Market capitalization represents the total value of Prelude Therapeutics as perceived by the stock market. It is calculated by multiplying the current stock price by the total number of outstanding shares.

Prelude Therapeutics (PRLD) Market Cap Formula = Stock Price * Shares Outstanding

The market cap of Prelude Therapeutics (PRLD) helps investors assess the company's size and compare it with competitors for better investment decisions.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

Prelude Therapeutics (PRLD) Market Cap History

DateMarket CapChange
Jun 2, 2025$51.22M-1.22%
May 1, 2025$51.85M-1.02%
Apr 1, 2025$52.39M+39.16%
Mar 3, 2025$37.65M-38.38%
Feb 3, 2025$61.09M-11.20%
Jan 2, 2025$68.80M+19.05%

Prelude Therapeutics (PRLD) End of Year Market Cap History

DateMarket CapChange
2025$54.99M-21.64%
2024$70.17M-70.03%
2023$234.11M-18.99%
2022$288.99M-50.81%
2021$587.54M-81.21%
2020$3.13B

FAQs About Prelude Therapeutics (PRLD) Market Cap

As of Jun 16, 2025, the market capitalization of Prelude Therapeutics (PRLD) is $54.99M. Market cap represents the total value of a company’s outstanding shares and is a key indicator of its size in the stock market.

In the last 30 days, Prelude Therapeutics’s market capitalization has increased by 3.94%, changing from $52.91M to $54.99M as of Jun 16, 2025.

In the last 3 months, Prelude Therapeutics’s market capitalization has increased by —, changing from – to – as of –.

In the year 2024, Prelude Therapeutics’s market capitalization decreased from $234.11M in January to $70.17M in December, reflecting a -70.03% change.

In the past five years, Prelude Therapeutics (PRLD) has had a compound annual growth rate (CAGR) of -53.20% in market capitalization. This means its market cap has shrunk at an average rate of -53.20% per year.

Prelude Therapeutics (PRLD)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.